A double-blind Randomized control trial to study the efficacy of combination of Taurine and L-Carnitine in alleviating muscle cramps in patients with liver cirrhosis.

This study is a double-blind, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of a combination of L-Carnitine (1g) and Taurine (3g) in alleviating muscle cramps in patients with liver cirrhosis. Muscle cramps are a common yet often overlooked complication in liver cirrhosis, significantly impacting patients’ quality of life.

Objectives: Primary Objective: To assess the effectiveness of L-Carnitine and Taurine in reducing the frequency, severity, and duration of muscle cramps in cirrhotic patients.Study Design:Population: 70 participants (35 in each group) aged 18–75 years with liver cirrhosis and experiencing at least 3 muscle cramps per week.Randomization: Participants will be randomly assigned to two groups:Group A: Receives L-Carnitine and Taurine combination as a sachet mixed with water daily for 3 months.Group B: Receives a placebo sachet daily for 3 months.Blinding: Double-blind design, ensuring both participants and investigators are unaware of group assignments.Key Measurements:Participants will maintain a symptom diary to record the frequency and duration of muscle cramps.The severity of cramps will be assessed using the Visual Analogue Scale (VAS).Follow-ups will be conducted monthly (via video and in-person consultations).Inclusion and Exclusion Criteria:Inclusion: Adults with liver cirrhosis experiencing frequent muscle cramps and willing to comply with study procedures.Exclusion: Patients with allergies to the study drugs, alcohol use in the past 3 months, or conditions like uncontrolled hepatic encephalopathy or chronic kidney disease.Expected Outcomes:This trial aims to demonstrate that the combination of L-Carnitine and Taurine is effective and safe for reducing muscle cramps in cirrhotic patients, potentially improving their overall well-being and quality of life.